Related Experiment Video
Updated: Sep 11, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Treatment Effects of the Integrated Perinatal Diabetes Education and Management Program
Loral Patchen1,2, Asli McCullers2, Serenity Budd2
1MedStar Washington Hospital Center, Washington, DC.
Objective:
The Integrated Perinatal Diabetes Education and Management Program (IP-DEMP) was launched to improve outcomes of pregnant and postpartum individuals with diabetes at a large, urban academic hospital system. The purpose of this study was to evaluate treatment outcomes achieved by program participants.
Research Design And Methods:
This retrospective cohort study compared diabetes treatment received by participants in the IP-DEMP with diabetes treatment in a historical comparison group at the same health care facility just before implementation of the IP-DEMP. Logistic regression was used to model the association of participation in the intervention with treatment, adjusting for covariates.
Results:
A total of 355 people were included in the analysis. Descriptive characteristics were similar between the intervention and comparison groups. Among participants with gestational diabetes mellitus (GDM), participation in the intervention group significantly increases the likelihood of receiving insulin, the gold-standard therapy during pregnancy. No significant differences in therapy received were observed among participants with different racial and ethnic identities.
Conclusion:
People with GDM who participated in the IP-DEMP were more likely to receive insulin therapy. Treatment received was not different for participants from historically marginalized groups.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Chronic Pancreatitis II: Collaborative Care
Assessment:

